The ominous history of chemical weapons

However, war is war. The deadly hatred that characterises it implies opposing armies will use everything at their disposal to defeat the opponent. As a result, the Allies took Putin's threat to deploy chemical weapons in Ukraine seriously. Sarin and tabun, two very poisonous chemicals, are un...

Oncology Pharmaceuticals Market to Grow at 11.9% CAGR during 2021-2029

Oncology is defined as study of different types of tumors and cancers such as brain tumor, blood cancer, along with its types such as anemia, hemophilia, leukemia, lymphomas, thalassemias, and cancer of other organs, with the intention of finding an effective cure and means of treatment of a part...

JAPAN HEALTH MINISTRY PANEL APPROVES PFIZER VACCINE FOR 12-15 YEAR OLDS

Highlights –

• Japan health ministry panel approves Pfizer vaccine for 12-15 year olds.
• The panel also gave the green light to extending the vaccine's maximum storage period.
• Pfizer has been working with the Pharmaceuticals and Medi...

JBCPL NOW HAS A PRESENCE IN INDIAN NEPHROLOGY SEGMENT

HIGHLIGHTS

• J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) enters the Nephrology segment in India
• RENOVA division of JBCPL caters to the needs of Chronic Kidney Disease patients in India.

J.B. Chemicals & Pharmaceuticals Ltd. (...

REATA PHARMACEUTICALS TO MAKE PRESENTATIONS AT UPCOMING MEDICAL CONFERENCES

HIGHLIGHTS

• Reata Pharmaceuticals Inc. is going to make presentations at upcoming medical conferences.
• Two conferences are going to take place in APR 2021 and JUNE 2021.

A clinical-stage biopharmaceutical company called Reata Pharmace...

India a Strong Competition

There is increased competition from India to Australia in the field of pharmaceuticals due to the rising demand and the investment in biological engineering which produces a potential revenue, and potential investments in that sector render India one of the most competitive marketplaces. There wi...

ITM and the German medical award

Recently ITM received the award of German medical 2019 with the most innovative product of the medical sector within outstanding benefit towards the patient and the advanced treatment and the efficient technology which they use every time. There are various group of companies who provide the avia...

Phase 1 SCB-313 for Malignant Pleural Effusion Treatment tested by Clover Biopharmaceuticals in Australia

According to an announcement by an international biotechnology company in China, Clover Biopharmaceuticals, thriving to develop new biological therapies, the first-ever cancer patient suffering from malignant pleural effusions was admitted in Australia in a fully human TRAIL-Trimer fusion protein...

Acquisition in the pharma world now a trend?

The pharmaceutical companies have been acquiring new assets and subsidiaries in order to take over their research and intellectual property this has become a growing trend in the pharmaceutical world. Here’s a look at some new acquisitions in pharma.
Alkem Laboratories Limited inform...